21,24-Dioxa-2,15,18,27,30,33-hexaazapentatriacontan-35-oic acid,30,33-bis(2-ethoxy-2-oxoethyl)-3,14,17,28-tetraoxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-, ethyl ester (494769-60-7)

Identification
Name:	21,24-Dioxa-2,15,18,27,30,33-hexaazapentatriacontan-35-oic acid,30,33-bis(2-ethoxy-2-oxoethyl)-3,14,17,28-tetraoxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-, ethyl ester
CAS:	494769-60-7
Molecular Formula:	C₇₀H₁₀₉N₇O₁₃
Molecular Structure:
Properties
Safety Data

Other Product

1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
(2R,3R)-N-{(1'S,2S,7'R,9'Z,17'S,20'S,21'S,29'S,32'R)-29'-benzyl-32'-[(1R)-1-hydroxyethyl]-7',20',28'-trimethyl-24'-[(1S)-1-methylpropyl]-11',14',18',22',25',27',30',33'-octaoxospiro[oxirane-2,8'-[6,15,19]trioxa[12,23,26,28,31,34]hexaazatricyclo[15.9.8.2~2
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
Glycine,N,N'-[[5-[1,12,15,26-tetraoxo-13-[[(1-oxohexadecyl)amino]methyl]-28-(1-pyrenyl)-5,8-dioxa-2,11,14,27-tetraazaoctacos-1-yl]-1,3-phenylene]bis(methylene)]bis[N-(2-ethoxy-2-oxoethyl)-, diethyl ester
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
21,24-Dioxa-2,15,18,27,30,33,36-heptaazaoctatriacontan-38-oic acid,30,33,36-tris(carboxymethyl)-3,14,17,28-tetraoxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-
21,24-Dioxa-2,15,18,27-tetraazanonacosan-29-oic acid,27-(carboxymethyl)-3,14,17-trioxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
11',29'-di-tert-butyl-5',17',23',35',38',40',43',45'-octamethyl-7',15',25',33'-tetraoxadispiro[cyclohexane-1,2'-heptacyclo[32.2.2.2~3,6~.2~16,19~.2~21,24~.1~9,13~.1~27,31~]hexatetracontane-20',1''-cyclohexane]-1'(36'),3',5',9'(44'),10',12',16',18',21',23'
6-Oxa-13,26-dithia-3,10,17,20,23,28,29,30-octaazatetracyclo[23.2.1.15,8.112,15]triaconta-5(30),12(29),14,25(28),27-pentaene-2,9,16,19,22-pentone,21-[1-(formyloxy)ethyl]-7,11-dimethyl-18-(1-methylpropyl)-4-(2-methylpropyl)-24-(phenylmethyl)-(9CI)
3,6-Dioxa-9,12,15-triazaheptadecan-17-oic acid,1-amino-12,15-bis(2-ethoxy-2-oxoethyl)-10-oxo-, ethyl ester
1/C23H22N2O2/c26-23(27-22-15-25-11-7-17(22)8-12-25)21-14-18(13-16-5-9-24-10-6-16)19-3-1-2-4-20(19)21/h1-6,9-10,13-14,17,22H,7-8,11-12,15H2/b18-13
somatotropin-releasing hormone (1-30)-amide, Ala(2)-Leu(15)-Nle(27)-GABA(30)-
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,3E)-1-hydroxy-2-methylpent-3-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-21-(1-methylethyl)-3,6,9,18,24-pentakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
Glycine,N,N'-[[5-[1,12,15,26-tetraoxo-13-[[(1-oxohexadecyl)amino]methyl]-28-(1-pyrenyl)-5,8-dioxa-2,11,14,27-tetraazaoctacos-1-yl]-1,3-phenylene]bis(methylene)]bis[N-(carboxymethyl)-